Best Life Insurance for COPD

Research Snapshot

• Topic: Best life insurance carriers for a U.S. consumer diagnosed with COPD.
• Target buyer: A consumer diagnosed with chronic obstructive pulmonary disease who understands that underwriting may consider severity, pulmonary-function testing, symptoms, medications, oxygen use, smoking history, hospitalizations, and overall stability.
• Use case: Life Insurance for COPD, United States, 2026.
• Platforms included (7): openai, anthropic, deepseek, grok, perplexity, kimi, google.
• Research date: 2026-09-22 (authoritative run date). Platform-reported dates are provenance metadata and do not independently prove freshness; deepseek reported 2026-01-15, 2026-05-13, and 2026-06-11 across entity bundles, and those discrepancies are disclosed as a methodology limitation.
• Unique entities named across platforms: 25.
• Qualifying entities: 10.
• Eligibility rule: Named by at least two platforms during ranking discovery.
• Ranking unit: Life insurance carrier.
• Identity scope: Company.

The Consensus Ranking

Questions This Section Answers

• What are the best life insurance carriers for COPD in 2026, ranked by how often AI platforms recommend them?
• Which COPD life insurance carrier was named by the most AI platforms, and how many platforms named each carrier?
• Which life insurance carriers for COPD have the best average listed position across the seven AI platforms studied?

The table below is the supplied final ranking. Order is determined by platform mentions, then average listed rank, then best listed rank. Platform mentions count only platforms that named the entity during ranking discovery; they do not represent the number of platforms that later completed a fit assessment.

Which Option Is Best for Which Version of the Buyer Need?

Questions This Section Answers

• Which life insurance carrier should a COPD applicant choose if they need guaranteed acceptance with no health questions?
• Is Mutual of Omaha or Prudential better for COPD when the applicant has mild, stable disease and wants larger term coverage?
• Which carrier for COPD has the highest published guaranteed-issue coverage limit, and which has the lowest published cost per dollar of coverage?

Buyer needs in COPD life insurance split into three distinct problems, and the ranking table maps cleanly onto them.

Guaranteed acceptance with no health questions. Mutual of Omaha ranks first overall and is the most frequently cited guaranteed-issue pathway, with guaranteed whole life available ages 45–85 (50–75 in New York) and no medical exam ^[1]. Physicians Mutual ranks seventh but carries the highest published guaranteed-issue ceiling in the evidence at up to $30,000 ^[3].

1. Mutual of Omaha

Questions This Section Answers

• Is Mutual of Omaha worth it for COPD life insurance, and what are its main drawbacks?
• What is the maximum coverage Mutual of Omaha offers a COPD applicant, and what happens if death occurs in the first two years?
• Does Mutual of Omaha require health questions for COPD applicants, or is its guaranteed-issue product truly no-questions-asked?

Verdict. Mutual of Omaha is the consensus leader of this index and the only carrier named by all seven platforms. Its strongest use case is modest final-expense coverage for applicants aged 45–85 whose COPD makes traditional underwriting difficult or impossible. It is a weaker fit for younger applicants, for buyers needing substantial income-replacement coverage, and for mild, stable COPD cases that could obtain better value through fully underwritten term insurance.

Why it ranked here. Mutual of Omaha received 7 platform mentions (100.0% share), an average listed position of 5.14, and a best position of 1. It was ranked first by deepseek and Physicians Mutual-adjacent openai analysis, and appeared in every platform's response. Its ranking reflects breadth of recognition rather than uniformly top placement: kimi and openai placed it seventh, while deepseek placed it first.

Best suited for. Applicants age 45–85 who need approximately $2,000–$25,000 of guaranteed-issue final-expense coverage; applicants with moderate or uncertain health who may qualify for simplified-issue Living Promise coverage; and applicants with COPD who cannot obtain affordable traditionally underwritten coverage but can accept higher premiums, limited face amounts, or a graded death benefit.

Main strengths for this use case. Guaranteed-issue whole life is available without medical underwriting for ages 45–85, subject to a narrower New York age range of 50–75 ^[5]. Living Promise Whole Life offers simplified underwriting with Level Benefit and Graded Benefit designs; producer materials show Level Benefit face amounts up to $50,000 and Graded Benefit face amounts of $2,000–$20,000 ^[6]. Independent research identifies Mutual of Omaha as a leading choice for current smokers with lung conditions requiring supplemental oxygen ^[7]. Whole-life premiums are fixed after issue and coverage continues for life if premiums are paid ^[8].

2. Prudential

Questions This Section Answers

• Is Prudential worth it for COPD life insurance, and what are its main drawbacks?
• Is Prudential or Banner Life better for COPD when the applicant wants fully underwritten term coverage?
• What rate class can a COPD applicant expect from Prudential, and does oxygen use disqualify them?

Verdict. Prudential ranks second and is the strongest alternative for applicants with mild or stable COPD who want meaningful term or permanent coverage and can provide complete medical records. It is not a guaranteed-acceptance carrier and should not be selected without a carrier-specific preassessment, especially for moderate-to-severe COPD or oxygen-dependent applicants.

Why it ranked here. Prudential received 6 platform mentions (85.7% share), an average listed position of 2.33, and a best position of 1. It was ranked first by anthropic, google, and kimi, third by grok, second by perplexity, and sixth by deepseek. Six of seven included platforms returned a usable fit assessment; the fit findings are not unanimous.

Best suited for. Applicants with mild or stable COPD who want meaningful term coverage and can provide complete medical records; applicants seeking permanent coverage and able to manage the higher premiums and policy charges of universal life; and applicants using an independent broker who can obtain an informal underwriting assessment before submitting a formal application.

Main strengths for this use case. Independent sources describe Prudential as evaluating COPD applications more favorably than many competitors, with specialized underwriting for respiratory conditions and consideration of the full health picture rather than declining solely on diagnosis ^[9]. Prudential is described as particularly strong for ex-smokers with three or more years of cessation ^[11]. Google-reported evidence cites a best-case scenario where applicants with mild, asymptomatic COPD or emphysema can qualify for Preferred Best rates if criteria are met, including FEV1 of 80% or greater stable for at least two years ^[12]. Prudential applies table ratings rather than outright denying coverage when a COPD applicant does not qualify for preferred rates, provided the condition is stable and monitored ^[13].

3. Banner Life

Questions This Section Answers

• Is Banner Life worth it for COPD life insurance, and what are its main drawbacks?
• Does Banner Life decline COPD applicants who use oxygen or have been hospitalized in the past year?
• What is Banner Life's annual policy fee, and how do table ratings affect the premium for a COPD applicant?

Verdict. Banner Life ranks third and is a mixed fit. OPTerm can be relevant for stable, mild COPD because Banner's underwriting guide indicates COPD is not categorically declined and substandard ratings may be available. It is materially less attractive for anyone seeking accelerated or no-exam underwriting, and for applicants with recent oxygen use, hospitalization, unstable symptoms, or advanced disease.

Why it ranked here. Banner Life received 5 platform mentions (71.4% share), an average listed position of 4.00, and a best position of 2. It was ranked second by kimi, third by perplexity, and fifth by anthropic, google, and grok.

Best suited for. Applicants with stable, mild COPD who can provide complete medical records and accept possible standard, tobacco, or table-rated pricing; applicants seeking level-premium term coverage with conversion potential and term lengths from 10 to 40 years; and applicants comfortable using an independent licensed agent for impairment-specific underwriting guidance.

Main strengths for this use case. COPD is not shown as an automatic decline in the cited OPTerm underwriting guide; the guide instead flags certain COPD situations for underwriting attention ^[14]. Traditional underwriting can consider the applicant's complete medical record rather than relying only on a simplified-issue questionnaire. OPTerm offers multiple term lengths, level initial premiums, renewable coverage, and conversion to universal life ^[15]. Table-rated underwriting is publicly identified as possible through table 12 subject to underwriting discretion ^[16]. Google-reported evidence indicates Banner typically underwrites mild COPD at Table 2 to Table 4 and moderate COPD at Table 4 to Table 6 ^[17].

Main limitations. COPD is excluded from Banner's cited accelerated-underwriting eligibility, so the buyer should not expect no-exam or instant approval ^[18]. Recent oxygen use or hospitalization within the prior year is specifically flagged for pre-submission underwriting contact ^[14].

4. Transamerica

Questions This Section Answers

• Is Transamerica worth it for COPD final expense coverage, and what are its main drawbacks?
• Does Transamerica offer day-one coverage for COPD, or is there a graded waiting period?
• Which Transamerica final expense product should a COPD applicant choose if they do not use supplemental oxygen?

Verdict. Transamerica ranks fourth and is a mixed-to-good fit. Its final-expense products can provide simplified-issue permanent coverage with relatively modest face amounts and no routine exam or laboratory requirement in the electronic process, but COPD underwriting remains material. It is a weaker candidate for severe COPD, oxygen dependence, current tobacco use, significant functional impairment, or larger coverage needs.

Why it ranked here. Transamerica received 5 platform mentions (71.4% share), an average listed position of 6.20, and a best position of 2. It was ranked second by openai, fourth by kimi, seventh by perplexity, eighth by grok, and tenth by anthropic — the widest spread among the top five.

Best suited for. Applicants with stable, mild-to-moderate COPD seeking permanent final-expense coverage; applicants who want $1,000–$50,000 of coverage and may prefer simplified underwriting over a full medical-exam process; and applicants able to answer detailed questions about symptoms, medications, pulmonary testing, tobacco use, oxygen, hospitalizations, and comorbidities.

Main strengths for this use case. Transamerica's published underwriting materials indicate that mild COPD may receive table 2–4 ratings and moderate COPD table 5–8 ratings, with severe COPD declined ^[20]. Google-reported evidence indicates that a COPD or emphysema diagnosis in the past four years triggers a single "Yes" in Part 3 of the medical questionnaire, leaving the applicant potentially eligible for Immediate Solution with full Day 1 coverage, provided they answer "No" to all other Part 3 questions ^[21]. Supplemental oxygen use is asked in Part 2 and disqualifies applicants from immediate coverage but may make them eligible for the Easy Solution graded plan ^[22]. Independent sources describe Transamerica as more flexible than most carriers when applicants have multiple conditions simultaneously, such as COPD combined with diabetes or heart disease ^[23].

5. Protective Life

Questions This Section Answers

• Is Protective Life worth it for COPD life insurance, and what are its main drawbacks?
• Does Protective Life decline COPD applicants who smoke or require oxygen therapy?
• What is Protective Life's dual-manual underwriting approach, and how does it affect table ratings for COPD?

Verdict. Protective Life ranks fifth and is a mixed-to-good fit. It may be a reasonable candidate for mild-to-moderate, stable COPD, particularly a nonsmoker or former smoker seeking fully underwritten term coverage. It is not demonstrated by the available public materials to be specifically COPD-friendly, and applicants with severe or unstable disease, oxygen use, recent hospitalizations, or materially impaired pulmonary function may need a carrier with more favorable pulmonary underwriting or a guaranteed-issue alternative.

Why it ranked here. Protective Life received 4 platform mentions (57.1% share), an average listed position of 3.50, and a best position of 2. It was ranked second by anthropic and grok, fourth by perplexity, and sixth by google. Kimi rated its fit "uncertain" because no independent source in the available research explicitly evaluates Protective's COPD underwriting.

Best suited for. Mild-to-moderate COPD that is stable and well documented; applicants willing to complete traditional underwriting and provide medical records or pulmonary testing; and consumers seeking level-premium term coverage with a potential conversion option.

Main strengths for this use case. Protective Classic Choice Term offers 10- to 40-year terms, coverage from $100,000 to $50 million on the consumer-facing product page, level premiums during the initial guaranteed period, and a conversion option that may allow conversion to permanent coverage without a new medical exam ^[24]. Independent underwriting experts identify Protective as having flexible underwriting for stable respiratory conditions, distinguishing it from carriers that automatically decline all but the mildest cases ^[25]. Google-reported evidence describes a dual-manual underwriting philosophy in which Protective evaluates applicants using two separate reinsurance manuals and applies the most favorable rate, which often yields a 2 to 3 table rating improvement for mild health conditions ^[27]. Protective's underwriting materials explicitly ask for COPD or emphysema type and symptom frequency, smoking status, hospitalization history, recent pulmonary function testing, and treatment type. .

6. Pacific Life

Questions This Section Answers

• Is Pacific Life worth it for COPD life insurance, and what are its main drawbacks?
• Does Pacific Life's PAL+ program allow no-exam coverage for COPD, or does COPD force traditional underwriting?
• What happens to a Pacific Life application if the COPD applicant uses oxygen routinely?

Verdict. Pacific Life ranks sixth and is a mixed fit. Its PAL+ process can route an applicant through no-exam, modified, or traditional underwriting, but Pacific Life specifically requires an attending physician statement for COPD under its underwriting guide and states that routine oxygen use in the prior 3–6 months is likely to result in decline. It may suit applicants with mild, stable COPD but not those with significant impairment, recent hospitalization, substantial oxygen use, or unstable disease.

Why it ranked here. Pacific Life received 4 platform mentions (57.1% share), an average listed position of 4.00, and a best position of 3. It was ranked third by anthropic and kimi, fourth by grok, and sixth by openai.

Best suited for. Applicants with mild or stable COPD who may qualify for standard or better underwriting; applicants seeking term coverage and willing to undergo traditional underwriting if accelerated underwriting is unavailable; and applicants who value a single PAL+ application process that can move from accelerated to modified to traditional underwriting.

Main strengths for this use case. PAL+ provides accelerated, modified, and traditional pathways; accelerated underwriting is described as no medical exam and no APS, modified underwriting as requiring a physical with labs completed within the prior 12 months, and traditional underwriting as involving additional requirements as needed ^[28]. Pacific Life explicitly addresses COPD in its underwriting guide rather than treating the condition as an unspecified medical issue ^[29]. Platform-reported evidence describes accelerated eligibility for ages 18–60, up to $3 million for specified term coverage, and standard or better risk class. Pacific Elite Term offers 10-, 20-, and 30-year level-premium periods, face amounts beginning at $250,000, conversion to eligible Pacific Life cash-value coverage, and multiple tobacco and non-tobacco risk classes ^[30]. Pacific Life holds an A+ (Superior) rating from A.M.

7. Physicians Mutual

Questions This Section Answers

• Is Physicians Mutual worth it for COPD guaranteed-issue coverage, and what are its main drawbacks?
• What is the maximum coverage Physicians Mutual offers a COPD applicant, and how does it compare with Mutual of Omaha?
• Does Physicians Mutual ask health questions for its guaranteed-issue whole life product?

Verdict. Physicians Mutual ranks seventh and is a good but narrowly targeted fit. Its guaranteed-issue Modified Whole Life is particularly relevant for COPD applicants who need modest final-expense coverage and cannot qualify for ordinary underwriting. Its two-year graded benefit, low maximum face amount relative to underwritten alternatives, potentially high cost per dollar, and lack of COPD-specific public underwriting detail prevent a stronger rating.

Why it ranked here. Physicians Mutual received 4 platform mentions (57.1% share), an average listed position of 5.25, and a best position of 1. It was ranked first by openai, fifth by kimi, seventh by grok, and eighth by anthropic. Its best position of 1 reflects openai's placement; its average position reflects wider spread.

Best suited for. Applicants ages 45–85 seeking guaranteed-issue permanent coverage up to $30,000; consumers with COPD who may not qualify for traditionally underwritten life insurance and mainly need funeral, debt, or final-expense funding; and applicants ages 45–70 who can answer health questions and want potentially higher coverage through Secure Essential, subject to approval.

Main strengths for this use case. Physicians Mutual's guaranteed-issue Modified Whole Life page states that applicants ages 45–85 receive guaranteed coverage with no health questions and no medical exam; COPD severity, pulmonary-function testing, symptoms, medications, oxygen use, smoking history, and hospitalizations therefore should not determine acceptance for that specific product ^[31]. Google-reported evidence states the plan offers coverage amounts up to $30,000, higher than the standard $25,000 limit offered by many guaranteed-issue competitors ^[32]. Platform-reported evidence describes Physicians Mutual as having the lowest average rates for guaranteed-issue life insurance, with average premiums of $72/month for women and $92/month for men at age 65 for $15,000 coverage. The company reports an A+ A.M. Best rating for Physicians Life Insurance Company as of November 2025 ^[33]. .

8. Lincoln Financial

Questions This Section Answers

• Is Lincoln Financial worth it for COPD life insurance, and what are its main drawbacks?
• Does Lincoln Financial's MoneyGuard product accept COPD applicants, or is COPD uninsurable for that product?
• What underwriting timeline should a COPD applicant expect from Lincoln Financial?

Verdict. Lincoln Financial ranks eighth and is a mixed fit. Its fully underwritten term and permanent products may suit applicants with mild-to-moderate, stable COPD, but Lincoln does not publicly disclose COPD-specific underwriting thresholds, likely rate classes, oxygen-use rules, or acceptance criteria. Applicants with severe or unstable COPD should compare multiple carriers through an independent broker rather than assume Lincoln is the best option.

Why it ranked here. Lincoln Financial received 4 platform mentions (57.1% share), an average listed position of 8.00, and a best position of 5. It was ranked fifth by perplexity, seventh by anthropic, and tenth by grok and kimi. Kimi rated its fit "uncertain" because no independent source names Lincoln among carriers recommended or known to be lenient for COPD.

Best suited for. Applicants with mild-to-moderate COPD, stable treatment, favorable pulmonary-function results, no recent hospitalizations, and no current tobacco use; consumers needing 10-, 15-, 20-, or 30-year term coverage and who may value conversion to a Lincoln permanent policy; and applicants seeking permanent coverage and able to tolerate higher premiums, policy charges, and ongoing funding requirements.

Main strengths for this use case. Independent insurance specialists identify Lincoln as competitive for COPD applicants; platform-reported evidence quotes industry experts stating Lincoln is competitive for applicants with diabetes, history of stroke, heart disease, stents, COPD, sleep apnea, asthma, hepatitis B or C, high blood pressure, high cholesterol, and prostate cancer ^[34]. Lincoln LifeElements Level Term is positioned for high-risk or complex medical histories and offers $250,000–$5 million coverage with 10–30 year terms ^[36]. Lincoln term policies include conversion privileges allowing eligible policyholders to switch to permanent life insurance without re-underwriting or new application, which is valuable for COPD applicants whose health may decline ^[37]. Lincoln Financial holds an A (Excellent) rating from AM Best and an A+ from S&P according to platform-reported evidence ^[38]. .

9. Corebridge Financial

Questions This Section Answers

• Is Corebridge Financial worth it for COPD life insurance, and what are its main drawbacks?
• Which Corebridge product should a COPD applicant choose if they have been hospitalized for COPD in the past two years?
• What is Corebridge's SimpliNow platform, and is it reliable for COPD applicants with complex health histories?

Verdict. Corebridge Financial ranks ninth overall but holds the best average listed position in the table (1.33) because the three platforms that named it placed it very high. It is a mixed-to-good fit. Select-a-Term may fit applicants with mild, stable COPD who can qualify through underwriting, while Guaranteed Issue Whole Life may fit applicants who are declined or unable to qualify medically but generally offers limited coverage and a restricted early death benefit.

Why it ranked here. Corebridge received 3 platform mentions (42.9% share), an average listed position of 1.33, and a best position of 1. It was ranked first by grok and perplexity and second by google. Six of seven included platforms returned a usable fit assessment; the fit findings are not unanimous.

Best suited for. Applicants with mild or stable COPD seeking level-premium term insurance and willing to undergo full underwriting; applicants who need flexible term durations and may qualify for standard, substandard, or otherwise individually priced coverage; and applicants with significant health issues who need a guaranteed-issue final-expense policy and can accept lower coverage and higher relative cost.

Main strengths for this use case. Corebridge publicly lists term, permanent, and final-expense life insurance; Select-a-Term is described as flexible term insurance with 18 available term periods, including 10 years, 15 through 30 years, and 35 years ^[39]. Google-reported evidence states Corebridge can offer up to Standard rates for individuals with mild changes in lung function due to COPD, provided they have never used oxygen and have no history of smoking-related complications ^[40]. SimpliNow Legacy is described as one of the few final expense options that can provide an offer for COPD with no hospitalization in the last two years ^[41].

10. Gerber Life Insurance

Questions This Section Answers

• Is Gerber Life Insurance worth it for COPD, and what are its main drawbacks?
• What is the maximum coverage Gerber Life offers a COPD applicant, and what happens if death occurs in the first two years?
• Is Gerber Life more expensive than Mutual of Omaha or Physicians Mutual for guaranteed-issue COPD coverage?

Verdict. Gerber Life Insurance ranks tenth and is a good fit for a narrow buyer: a U.S. consumer with COPD who is age 50–80, needs modest permanent coverage for final expenses, and may be declined or heavily rated by medically underwritten insurers. It is not a strong fit for substantial income-replacement coverage, mortgage protection, or buyers younger than 50.

Why it ranked here. Gerber Life received 2 platform mentions (28.6% share), an average listed position of 3.00, and a best position of 2. It was ranked second by deepseek and fourth by google. It is the only entity in the ranking named by fewer than three platforms, which is why it ranks last despite a favorable average position.

Best suited for. Applicants age 50–80 whose COPD or related health history makes traditional underwriting difficult; final-expense needs, small debts, or a modest legacy benefit; and buyers who prioritize guaranteed acceptance and fixed premiums over low cost per dollar of coverage.

Main strengths for this use case. The recommended product does not require a medical exam or health questions and states that acceptance is guaranteed regardless of health; COPD severity, pulmonary-function testing, symptoms, medications, oxygen use, smoking history, hospitalizations, and stability should not determine acceptance for this specific product ^[42]. Gerber states that the premium is locked when coverage begins and generally does not increase because of age or health, subject to changes in coverage, payment method, or payment frequency ^[43]. The policy is whole life insurance intended to remain in force for life while premiums are paid, and it builds cash value ^[42]. Gerber Life Insurance Company is rated A+ (Superior) by AM Best according to platform-reported evidence ^[44].

What the Cross-Platform Study Reveals About This Market

Questions This Section Answers

• What does the cross-platform AI study reveal about how COPD life insurance underwriting is described across carriers?
• Which COPD life insurance carriers appear in both guaranteed-issue and fully underwritten recommendations across the seven platforms?

Three structural patterns emerge from the ten qualifying entities.

First, the market splits into two underwriting philosophies, and the ranking reflects both. Five of the ten ranked carriers — Mutual of Omaha, Transamerica, Physicians Mutual, Corebridge Financial, and Gerber Life Insurance — are cited primarily for guaranteed-issue or simplified-issue pathways that reduce or eliminate COPD underwriting. The other five — Prudential, Banner Life, Protective Life, Pacific Life, and Lincoln Financial — are cited primarily for fully underwritten term or permanent coverage where COPD severity, pulmonary-function results, oxygen use, smoking history, and hospitalizations materially affect the offer. Mutual of Omaha is the only carrier that appears prominently in both categories, which explains its unanimous first-place ranking.

Second, oxygen use is the single most consistent dividing line across platforms. Every platform that discussed oxygen use treated it as a threshold event.

Where the AI Platforms Agreed

Questions This Section Answers

• On which COPD life insurance facts did all seven AI platforms agree?
• Which carrier did every AI platform name for COPD life insurance?

Platforms agreed on several material points.

Mutual of Omaha is the most recognized COPD carrier. All seven platforms named it, and no other entity achieved 100% share. Platforms agreed that its guaranteed-issue whole life product removes COPD underwriting for eligible ages and that its Living Promise product offers a simplified-issue middle option ^[45].

COPD underwriting considers a consistent set of factors. Platforms repeatedly identified severity, pulmonary-function testing, symptoms, medications, oxygen use, smoking history, hospitalizations, and overall stability as the material underwriting inputs ^[52]. .

Where the AI Platforms Disagreed

Questions This Section Answers

• Where did the AI platforms disagree about COPD life insurance underwriting for the same carriers?
• Which COPD life insurance carrier had the widest disagreement among AI platforms about fit?

Disagreements were substantive and are preserved here rather than resolved.

Whether COPD is an automatic decline at specific carriers. Grok reported that RiskQuoter lists COPD as automatic decline at Banner Life, while MoneyGeek and underwriting excerpts indicate possible coverage for stable mild cases without oxygen or hospitalization ^[62]. Google reported that COPD and emphysema disqualify applicants from Pacific Life's fluidless accelerated underwriting pathways, while perplexity reported that Banner Life's accelerated-underwriting eligibility materials explicitly include COPD in one version ^[63].

Whether Prudential is the most COPD-friendly major carrier. Kimi reported that Prudential is widely known among brokers as the most COPD-friendly major carrier, often offering Table 4 ratings where competitors decline, but noted that broker claims lack independent actuarial verification ^[65].

How Buyers Should Choose

Questions This Section Answers

• What should a buyer check before choosing a life insurance carrier for COPD?
• How should a COPD applicant decide between guaranteed-issue and fully underwritten life insurance?

The ranking table is a starting point, not a decision. Buyers should work through four steps.

Step 1: Classify COPD severity using objective measures. The evidence consistently identifies pulmonary-function testing, particularly FEV1, as the primary underwriting metric ^[66]. Mild COPD is generally described as FEV1 of 60% or higher, moderate as 50–59%, and severe as below 40% ^[68]. Buyers should obtain recent spirometry results before applying.

Step 2: Determine whether oxygen use is present. Oxygen use is the most consistent disqualifier for fully underwritten coverage across the evidence ^[70]. Applicants who use oxygen routinely should focus on guaranteed-issue carriers — Mutual of Omaha, Physicians Mutual, and Gerber Life Insurance — rather than applying to fully underwritten carriers first. .

Methodology

This index was produced from a single standardized prompt sent once to each of seven AI platforms on September 22, 2026. The prompt asked which life insurance carriers are generally worth considering for applicants with COPD and why, and it specified that underwriting may consider severity, pulmonary-function testing, symptoms, medications, oxygen use, smoking history, hospitalizations, and overall stability.

Platforms included: openai (gpt-5.6-luna, native search), anthropic (claude-haiku-4-5-20251001, native search), deepseek (deepseek-v4-flash, no search enabled), grok (x-ai/grok-4.3, server tool search), perplexity (perplexity/sonar, native options), kimi (moonshotai/kimi-k2.6, web plugin), and google (gemini-3.5-flash, native search).

Ranking rule. Entities were ranked by platform mentions, then average listed position, then best listed rank. Platform mentions count only platforms that named the entity during ranking discovery. They do not represent the number of platforms that later completed a fit assessment.

Eligibility rule. An entity qualified for the final ranking if it was named by at least two platforms. Twenty-five unique entities were named; ten qualified.

Evidence handling. Entity evidence bundles were the authority for buyer fit, features, pricing, strengths, limitations, disagreements, and citations.

Methodology Limitations

Several limitations materially affect how this index should be used.

Single prompt, single run. The study used one standardized prompt sent once to each included platform. AI answers can vary by date, wording, location, account state, model, interface, browsing configuration, and the sources retrieved. A different prompt or a different day could produce a different ranking.

Platform-reported dates differ from the run date. The authoritative research date is 2026-09-22. Deepseek reported 2026-01-15, 2026-05-13, and 2026-06-11 across entity bundles. Platform-reported dates are provenance metadata and do not independently prove freshness.

Platform mentions are not fit assessments. Platform mentions count only ranking-discovery mentions. Six of seven included platforms returned a usable fit assessment for Prudential and Corebridge Financial; the fit findings for those entities are not unanimous.

Citations are platform-reported evidence, not independently verified facts. No-search model claims require explicit verification before being described as current facts. Deepseek ran without search enabled.

URLs were not independently validated. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. .

Final Verdict

Mutual of Omaha is the consensus leader for COPD life insurance in this 7-platform study, named by all seven platforms and cited most frequently for guaranteed-issue and simplified-issue pathways that remove COPD underwriting for eligible applicants. Prudential is the strongest alternative for mild-to-moderate, stable COPD seeking fully underwritten term or permanent coverage, and it is the most frequently cited carrier for favorable respiratory underwriting. Banner Life, Transamerica, and Protective Life follow as term-oriented or final-expense alternatives with distinct tradeoffs. Physicians Mutual offers the highest published guaranteed-issue ceiling at up to $30,000. Corebridge Financial holds the best average listed position despite ranking ninth by mentions. Gerber Life Insurance is the narrowest guaranteed-acceptance option, suited to ages 50–80 needing modest final-expense coverage.

The ranking is a consensus-breadth ordering, not a quality ordering. Buyers should use it to build a shortlist, then verify COPD-specific underwriting, coverage limits, graded-benefit terms, and current pricing directly with each carrier or through an independent broker before applying.